Literature DB >> 2952659

Characterization of Ca2+-dependent phospholipid binding and phosphorylation of lipocortin I.

D D Schlaepfer, H T Haigler.   

Abstract

Lipocortin I is a high affinity substrate for the epidermal growth factor receptor/kinase that can be purified by reversible Ca2+-dependent association with cellular particulate fractions. Purified human lipocortin I was shown by ultraviolet spectroscopy to undergo conformational changes in response to high concentrations of Ca2+ (30-700 microM). Equilibrium dialysis of lipocortin I alone against 45Ca2+ showed barely detectable binding at 5-60 microM Ca2+. However, in the presence of phosphatidylserine, binding was significantly enhanced, and Scatchard analysis of the binding data showed that lipocortin I contained four Ca2+-binding sites with an apparent Kd of 75 microM. Lipocortin I associated with phosphatidylserine vesicles and F-actin in a Ca2+-dependent manner with half-maximal association occurring at 22 and 180 microM Ca2+, respectively. Neither phosphatidylcholine vesicles nor intact cultured fibroblasts bound detectable amounts of lipocortin I. Phosphorylation of lipocortin I by the epidermal growth factor-stimulated kinase in A431 membranes required Ca2+ (half-maximum = 28 microM) in the presence of Mg2+, but phosphorylation was not Ca2+-dependent in the presence of Mn2+. The difference in Ca2+ requirement for phosphorylation probably is a reflection of the fact that Mn2+, but not Mg2+, promoted the association of lipocortin I with phospholipid. Although the physiological role of lipocortin I phosphorylation has not yet been determined, it was observed that phosphorylation of Tyr-21 reduced by 5-fold the amount of Ca2+ required for half-maximal association of the protein with phosphatidylserine vesicles.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2952659

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Activation and regulation of protein kinase C enzymes.

Authors:  G L Nelsestuen; M D Bazzi
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

Review 2.  Stimulus-response coupling: the search for intracellular calcium mediator proteins.

Authors:  V L Smith; M A Kaetzel; J R Dedman
Journal:  Cell Regul       Date:  1990-01

Review 3.  Factors controlling permeability of the blood-brain barrier.

Authors:  Mohammed M A Almutairi; Chen Gong; Yuexian G Xu; Yanzhong Chang; Honglian Shi
Journal:  Cell Mol Life Sci       Date:  2015-09-24       Impact factor: 9.261

Review 4.  Annexins: putative linkers in dynamic membrane-cytoskeleton interactions in plant cells.

Authors:  D Konopka-Postupolska
Journal:  Protoplasma       Date:  2007-04-24       Impact factor: 3.356

5.  Purification and partial sequence analysis of plant annexins.

Authors:  M Smallwood; J N Keen; D J Bowles
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

6.  Evidence for specific annexin I-binding proteins on human monocytes.

Authors:  N J Goulding; L Pan; K Wardwell; V C Guyre; P M Guyre
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

7.  The association of annexin I with early endosomes is regulated by Ca2+ and requires an intact N-terminal domain.

Authors:  J Seemann; K Weber; M Osborn; R G Parton; V Gerke
Journal:  Mol Biol Cell       Date:  1996-09       Impact factor: 4.138

8.  A dimeric form of lipocortin-1 in human placenta.

Authors:  R B Pepinsky; L K Sinclair; E P Chow; B O'Brine-Greco
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

9.  In vivo and in vitro phosphorylation of annexin II in T cells: potential regulation by annexin V.

Authors:  T Dubois; J P Oudinet; F Russo-Marie; B Rothhut
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

10.  Biochemical characterization of murine glycosylation-inhibiting factor.

Authors:  Y Tagaya; A Mori; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.